Literature DB >> 24398329

Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura.

Yang Jiang1, Jennifer J McIntosh, Jessica A Reese, Cassandra C Deford, Johanna A Kremer Hovinga, Bernhard Lämmle, Deirdra R Terrell, Sara K Vesely, Eric J Knudtson, James N George.   

Abstract

UNLABELLED: Pregnancy may precipitate acute episodes of thrombotic thrombocytopenic purpura (TTP), but pregnancy outcomes in women who have recovered from acquired TTP are not well documented. We analyzed pregnancy outcomes following recovery from TTP associated with acquired, severe ADAMTS13 deficiency (ADAMTS13 activity <10%) in women enrolled in the Oklahoma TTP-HUS Registry from 1995 to 2012. We also systematically searched for published reports on outcomes of pregnancies following recovery from TTP associated with acquired, severe ADAMTS13 deficiency. Ten women in the Oklahoma Registry had 16 subsequent pregnancies from 1999 to 2013. Two women had recurrent TTP, which occurred 9 and 29 days postpartum. Five of 16 pregnancies (31%, 95% confidence interval, 11%-59%) in 3 women were complicated by preeclampsia, a frequency greater than US population estimates (2.1%-3.2%). Thirteen (81%) pregnancies resulted in normal children. The literature search identified 382 articles. Only 6 articles reported pregnancies in women who had recovered from TTP associated with acquired, severe ADAMTS13 deficiency, describing 10 pregnancies in 8 women. TTP recurred in 6 pregnancies.
CONCLUSIONS: With prospective complete follow-up, recurrent TTP complicating subsequent pregnancies in Oklahoma patients is uncommon, but the occurrence of preeclampsia may be increased. Most pregnancies following recovery from TTP in Oklahoma patients result in normal children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24398329      PMCID: PMC3954049          DOI: 10.1182/blood-2013-11-538900

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Maternal body mass index and the risk of preeclampsia: a systematic overview.

Authors:  Tara E O'Brien; Joel G Ray; Wee-Shian Chan
Journal:  Epidemiology       Date:  2003-05       Impact factor: 4.822

2.  ADAMTS13 activity and the risk of thrombotic thrombocytopenic purpura relapse in pregnancy.

Authors:  Rachna Raman; Shangbin Yang; Haifeng M Wu; Spero R Cataland
Journal:  Br J Haematol       Date:  2011-01-31       Impact factor: 6.998

Review 3.  Microangiopathic disorders in pregnancy.

Authors:  Salley G Pels; Michael J Paidas
Journal:  Hematol Oncol Clin North Am       Date:  2011-04       Impact factor: 3.722

4.  Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura.

Authors:  Cassandra C Deford; Jessica A Reese; Lauren H Schwartz; Jedidiah J Perdue; Johanna A Kremer Hovinga; Bernhard Lämmle; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Blood       Date:  2013-07-09       Impact factor: 22.113

5.  Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

Authors:  Sara K Vesely; Xiaoning Li; J R McMinn; Deirdra R Terrell; James N George
Journal:  Transfusion       Date:  2004-08       Impact factor: 3.157

6.  Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004.

Authors:  Anne B Wallis; Audrey F Saftlas; Jason Hsia; Hani K Atrash
Journal:  Am J Hypertens       Date:  2008-03-13       Impact factor: 2.689

7.  Hypertensive disorders and severe obstetric morbidity in the United States.

Authors:  Elena V Kuklina; Carma Ayala; William M Callaghan
Journal:  Obstet Gynecol       Date:  2009-06       Impact factor: 7.661

8.  Pregnancy-associated thrombotic thrombocytopenic purpura.

Authors:  Jens Gerth; Ekkehard Schleussner; Karim Kentouche; Martin Busch; Mandy Seifert; Gunter Wolf
Journal:  Thromb Haemost       Date:  2009-02       Impact factor: 5.249

9.  Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997-2008.

Authors:  Reeta Lamminpää; Katri Vehviläinen-Julkunen; Mika Gissler; Seppo Heinonen
Journal:  BMC Pregnancy Childbirth       Date:  2012-06-11       Impact factor: 3.007

10.  Management of Thrombotic Thrombocytopenic Purpura with Autoantibodies to ADAMTS-13 and Concurrent Preeclampsia in Pregnancy: Multidisciplinary Team Approach.

Authors:  Tiffany Patrick; Steve J Carlan; Jose Eugenio Najera; Julie Eastwood
Journal:  AJP Rep       Date:  2012-02-22
View more
  13 in total

Review 1.  TTP: long-term outcomes following recovery.

Authors:  James N George
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Thrombocytopenia in pregnancy.

Authors:  Douglas B Cines; Lisa D Levine
Journal:  Blood       Date:  2017-06-21       Impact factor: 22.113

3.  High-Mobility Group Box 1 From Hypoxic Trophoblasts Promotes Endothelial Microparticle Production and Thrombophilia in Preeclampsia.

Authors:  Yae Hu; Ruhong Yan; Ce Zhang; Zhichao Zhou; Meng Liu; Can Wang; Hong Zhang; Liang Dong; Tiantian Zhou; Yi Wu; Ningzheng Dong; Qingyu Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-04-12       Impact factor: 8.311

Review 4.  Thrombocytopenia in pregnancy.

Authors:  Douglas B Cines; Lisa D Levine
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  High frequency of decreased antithrombin level in pregnant women with thrombosis.

Authors:  Yuki Kamimoto; Hideo Wada; Makoto Ikejiri; Kaname Nakatani; Takashi Sugiyama; Kazuhiro Osato; Nao Murabayashi; Norikazu Yamada; Takeshi Matsumoto; Kohshi Ohishi; Hidehiro Ishikawa; Hidekazu Tomimoto; Masaaki Ito; Tomoaki Ikeda
Journal:  Int J Hematol       Date:  2015-07-02       Impact factor: 2.490

6.  Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura.

Authors:  Jenna Brown; Bindu Potugari; Marshall A Mazepa; Ruhail Kohli; Alison R Moliterno; Robert A Brodsky; Jason A Vaught; Richard Burwick; Shruti Chaturvedi
Journal:  Ann Hematol       Date:  2022-08-06       Impact factor: 4.030

7.  Clinical characteristics, triggering etiologies, and response of plasmapheresis in thrombotic microangiopathy in Taiwan.

Authors:  Ching-Hu Chung; I-Jung Tsai; Min-Hua Tseng; Hsin-Hsu Chou; You-Lin Tain; Jeng-Daw Tsai; Yuan-Yow Chiou; Yee-Hsuan Chiou; Ching-Yuang Lin
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 8.  Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist.

Authors:  Juliana Perez Botero; Jessica A Reese; James N George; Jennifer J McIntosh
Journal:  Am J Hematol       Date:  2021-09-04       Impact factor: 10.047

9.  Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study.

Authors:  Barbara Ferrari; Alberto Maino; Luca A Lotta; Andrea Artoni; Silvia Pontiggia; Silvia M Trisolini; Alessandra Malato; Frits R Rosendaal; Flora Peyvandi
Journal:  Orphanet J Rare Dis       Date:  2014-11-28       Impact factor: 4.123

10.  Autoimmune Thrombotic Thrombocytopenic Purpura: Two Rare Cases Associated with Juvenile Idiopathic Arthritis and Multiple Sclerosis.

Authors:  Despoina Dimopoulou; Athina Dimosiari; Eudokia Mandala; Theodoros Dimitroulas; Alaxandros Garyfallos
Journal:  Front Med (Lausanne)       Date:  2017-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.